BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 19189072)

  • 1. Tumor initiating cells in malignant gliomas: biology and implications for therapy.
    Hadjipanayis CG; Van Meir EG
    J Mol Med (Berl); 2009 Apr; 87(4):363-74. PubMed ID: 19189072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliomagenesis and the use of neural stem cells in brain tumor treatment.
    Achanta P; Sedora Roman NI; Quiñones-Hinojosa A
    Anticancer Agents Med Chem; 2010 Feb; 10(2):121-30. PubMed ID: 20184546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial progenitors as targets for transformation in glioma.
    Ilkhanizadeh S; Lau J; Huang M; Foster DJ; Wong R; Frantz A; Wang S; Weiss WA; Persson AI
    Adv Cancer Res; 2014; 121():1-65. PubMed ID: 24889528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel treatment strategies for malignant gliomas using neural stem cells.
    Oh MC; Lim DA
    Neurotherapeutics; 2009 Jul; 6(3):458-64. PubMed ID: 19560736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Advances in biology and treatment of malignant brain gliomas. Stem cells and neurosciences.
    Maira G; Fernandez E
    Neurol Res; 2006 Jul; 28(5):471-3. PubMed ID: 16808874
    [No Abstract]   [Full Text] [Related]  

  • 6. Glioma stem cells: a midterm exam.
    Stiles CD; Rowitch DH
    Neuron; 2008 Jun; 58(6):832-46. PubMed ID: 18579075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells and glioma.
    Das S; Srikanth M; Kessler JA
    Nat Clin Pract Neurol; 2008 Aug; 4(8):427-35. PubMed ID: 18628751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cancer stem cells through L1CAM suppresses glioma growth.
    Bao S; Wu Q; Li Z; Sathornsumetee S; Wang H; McLendon RE; Hjelmeland AB; Rich JN
    Cancer Res; 2008 Aug; 68(15):6043-8. PubMed ID: 18676824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SVZ and Its Relationship to Stem Cell Based Neuro-oncogenesis.
    Kusne Y; Sanai N
    Adv Exp Med Biol; 2015; 853():23-32. PubMed ID: 25895705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4.
    Ehtesham M; Yuan X; Kabos P; Chung NH; Liu G; Akasaki Y; Black KL; Yu JS
    Neoplasia; 2004; 6(3):287-93. PubMed ID: 15153341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma stem cell signaling: therapeutic opportunities and challenges.
    Dietrich J; Diamond EL; Kesari S
    Expert Rev Anticancer Ther; 2010 May; 10(5):709-22. PubMed ID: 20470003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Instability of cell phenotype and tumor initiating cells in gliomas].
    Junier MP; Sharif A
    Biol Aujourdhui; 2011; 205(1):63-74. PubMed ID: 21501577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas.
    Chan XH; Nama S; Gopal F; Rizk P; Ramasamy S; Sundaram G; Ow GS; Ivshina AV; Tanavde V; Haybaeck J; Kuznetsov V; Sampath P
    Cell Rep; 2012 Sep; 2(3):591-602. PubMed ID: 22921398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential origin of glioblastoma initiating cells.
    Chesler DA; Berger MS; Quinones-Hinojosa A
    Front Biosci (Schol Ed); 2012 Jan; 4(1):190-205. PubMed ID: 22202053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.
    Westphal M; Lamszus K
    Nat Rev Neurosci; 2011 Aug; 12(9):495-508. PubMed ID: 21811295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
    Zhao B; Bian EB; Li J; Li J
    J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse induced glioma-initiating cell models and therapeutic targets.
    Kondo T
    Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties.
    Wu A; Oh S; Wiesner SM; Ericson K; Chen L; Hall WA; Champoux PE; Low WC; Ohlfest JR
    Stem Cells Dev; 2008 Feb; 17(1):173-84. PubMed ID: 18271701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
    Ogden AT; Waziri AE; Lochhead RA; Fusco D; Lopez K; Ellis JA; Kang J; Assanah M; McKhann GM; Sisti MB; McCormick PC; Canoll P; Bruce JN
    Neurosurgery; 2008 Feb; 62(2):505-14; discussion 514-5. PubMed ID: 18382330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.